James Brumley
James Brumley (RSS)
InvestorPlace Feature Writer

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He's now primarily a freelance writer, tapping more than a decade's worth of broad experience to help investors get more out of the market.

Read complete bio
Recent Articles

Why CSX Corporation (CSX), Target Corporation (TGT) and Cameco Corp (USA) (CCJ) Are 3 of Today’s Worst Stocks

Jan. 18, 2017, 4:39 pm EST – Cameco (CCJ), Target (TGT) and CSX used more than their fair share of red ink on Wednesday. Here's what you need to know. More 

Why Facebook Inc (FB) Stock Will Outshine the Snapchat IPO

Jan. 18, 2017, 1:34 pm EST – FB stock may never relive its post-IPO glory days, but Facebook on its worst day is still a more potent investment than Snapchat on its best day. More 

Why the Amgen, Inc. (AMGN) Patent Case Is So Important

Jan. 18, 2017, 12:02 pm EST – Amgen (AMGN) is pursuing a court case that will force the legal system to make a decision that will essentially become statute. More 

Why Qualcomm, Inc. (QCOM), JPMorgan Chase & Co. (JPM) and Arista Networks Inc (ANET) Are 3 of Today’s Worst Stocks

Jan. 17, 2017, 4:47 pm EST – Arista Networks (ANET), JPMorgan Chase (JPM) and Qualcomm (QCOM) led Tuesday's bearish charge, for all the right reasons. More 

Square Inc (SQ) Stock Is Red-Hot for All the Right Reasons

Jan. 17, 2017, 12:05 pm EST – Square stock has been red hot of late, and that has some investors worried. SQ investors need not worry though -- analysts have this one right. More 

Valeant Pharmaceuticals Intl Inc (VRX) Can’t Escape This Endless Pit

Jan. 17, 2017, 10:32 am EST – Valeant Pharmaceuticals (VRX) is in more debt than it can handle, and it doesn't have a potent enough portfolio to keep its head above water. More 

Biogen Inc (BIIB) Will Win a Battle, But Could Lose the War

Jan. 17, 2017, 8:24 am EST – Biogen (BIIB) has a new blockbuster drug in Spinraza, but BIIB stock holders shouldn't cheer yet. Its pricing is quickly developing enemies. More 

Why Infosys Ltd ADR (INFY), GameStop Corp. (GME) and Hovnanian Enterprises, Inc. (HOV) Are 3 of Today’s Worst Stocks

Jan. 13, 2017, 4:36 pm EST – Infosys (INFY), Hovnanian Enterprises (HOV) and GameStop (GME) each used more than their fair share of red ink on Friday. More 

Don’t Sweat Analysts’ Unenthused Response to Tesla Motors Inc (TSLA) Battery Factory

Jan. 13, 2017, 1:05 pm EST – Tesla Motors (TSLA) got rave reviews for its recently opened battery gigafactory, and investors need not worry about the doubts being voiced. More 

Bank of America Corp (BAC) Q4 Justifies Months of Buying

Jan. 13, 2017, 9:09 am EST – Don't sweat Friday's pause. Bank of America (BAC) fourth-quarter earnings support the bullish case that has propped BAC stock up for months. More